Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,419
Total Claims
$1.6M
Drug Cost
763
Beneficiaries
$2,107
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+46%
Opioid rate vs peers
50.8% vs 34.8% avg
+399%
Cost per patient vs peers
$2,107 vs $422 avg
+30%
Brand preference vs peers
6.2% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
50.8%
Opioid Rate
9,870
Opioid Claims
$1.1M
Opioid Cost
24.6%
Long-Acting Rate
This provider's opioid prescribing rate of 50.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,198 claims · $980K
Generic: 18,221 claims · $628K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 241 | $324K |
| Methylnaltrexone Bromide | 72 | $175K |
| Oxycodone Myristate | 202 | $142K |
| Oxycodone Hcl/Acetaminophen | 2,068 | $107K |
| Hydrocodone/Acetaminophen | 2,454 | $76K |
| Oxycodone Hcl | 2,026 | $65K |
| Tapentadol Hcl | 39 | $64K |
| Oxycodone Hcl/Acetaminophen | 11 | $48K |
| Fentanyl | 299 | $39K |
| Ubrogepant | 27 | $37K |
| Hydrocodone Bitartrate | 52 | $37K |
| Naloxone Hcl | 413 | $36K |
| Morphine Sulfate | 968 | $35K |
| Erenumab-Aooe | 35 | $33K |
| Buprenorphine Hcl | 56 | $32K |
Prescribing Profile
84
Unique Drugs
24.0
Anomaly Score
Patient Profile
66
Avg Age
63%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data